This paper proposes for the first time that Notch1 and Hes1 can be used as potential biomarkers to assist in the monitoring of tuberculosis-induced moderate/severe lung disease, providing novel ideas and directions to support clinical monitoring and therapeutic effect observation. This evidence concerns the gene NOTCH1 and tuberculosis.